| Medical Marijuana ProCon |
HOME | CLOSE |
| 1. | Name: | Joep Killestein, M.D., Ph.D. | |||||||||
| 2. | Title: | Department of Neurology, MS Centre, VU Medical Centre, Amsterdam, The Netherlands | |||||||||
| 3. | Medical Marijuana Position: |
No position found to the question "Should marijuana be a medical option?" | |||||||||
| 4. | Reasoning: | "The authors conducted a randomized, double-blind, placebo-controlled, twofold crossover study in 16 patients with MS who presented with severe spasticity to investigate safety, tolerability, and efficacy of oral Delta(9)-Tetrahydrocannabinol (THC) and Cannabis sativa plant extract. Both drugs were safe, but adverse events were more common with plant-extract treatment. Compared with placebo, neither THC nor plant-extract treatment reduced spasticity. Both THC and plant-extract treatment worsened the participant's global impression." ("Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS," Neurology 5/02) |
|||||||||
| 5. |
Credibility Ranking: |
|
|||||||||
| 6. | Involvement: |
|
|||||||||
| 7. | Education: |
|
|||||||||
| 8. | Relevant Affiliations/Honors: |
|
|||||||||
| 9. | Contact Info: |
|
|||||||||
| 10. | Other: |
Select Publications:
|
|||||||||
| HOME | CLOSE |